John Lupisella
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 17, 2026
From Lead to Clinical Candidate: Discovery of BMS-986331 as a Potent and Selective N-Formyl Peptide Receptor 2 Agonist.Pravin S Shirude, Daniel Cheney, Amit K Chattopadhyay
|Apr 03, 2025
Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis.Andreas Margraf, Jianmin Chen, Marilena Christoforou
|Sep 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 Agonists.Nicholas R Wurtz, Pravin S Shirude, Daniel L Cheney
|Oct 21, 2022
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial Infarction.John Lupisella, Stéphane St-Onge, Marilyn Carrier
|Jun 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists.Nicholas R Wurtz, James A Johnson, Andrew Viet
Pageof 1
Frequent Collaborators
4 joint publications
Nicholas R Wurtz
4 joint publications
Ellen K Kick
2 joint publications
Ruth R Wexler
2 joint publications
Michel Bouvier
1 joint publications
James A Johnson
1 joint publications
Andreas Margraf
1 joint publications
Chiara Cecconello
1 joint publications
Paul R C Imbert
1 joint publications
Thomas D Wright
1 joint publications
Stefan Russo
